Therefore, we used NGF antibody panel to assess the level of infiltration with clonal plasma cells along with BM cellular composition in MM patients with BR and compared the results to those obtained in patients with complete remission (CR) MRD-negative (MRDneg) and patients with clinical relapse (relapsed MM, RMM). This evidence concerns the gene NGF and Miyoshi myopathy.